Culture Biosciences key facts
as of Oct 2026- Developer of automated bioreactors and software designed to help companies optimize their manufacturing processes.
- Culture Biosciences is valued at approximately $290.0M as of Oct 2026, set at its later-stage round, Sep 2021; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $107.2M across 1 recorded rounds; the latest was Early Stage VC ($21.6M) in Feb 2020.
- Notable investors include Y Combinator, US National Science Foundation, BoxGroup, DCVC, Craft Ventures — 26 tracked in total.
- Culture Biosciences has filed 1 Form D with the SEC, most recently Mar 2020 ($21.6M sold to 38 investors).
- Status: Privately Held (backing).
Valued at $290.0M at its later-stage round, Sep 2021. Nothing has traded since.
- ·The complete investor list: 26 names
- ·Watch Culture Biosciences: the Monday email on marks, rounds and moves
Culture Biosciences funding rounds
1 roundsWho backs Culture Biosciences
26+Culture Biosciences valuation
Culture Biosciences was valued at $290 million at its later-stage round in Sep 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Culture Biosciences raised?
Culture Biosciences has raised $107 million in total; 1 of its rounds is on record. The largest on record was a $21.6 million early-stage round in Feb 2020.
Culture Biosciences has filed 1 Form D with the SEC, most recently in Mar 2020 ($21.6 million sold to 38 investors).
Culture Biosciences investors
26 investors are on record for Culture Biosciences, including Y Combinator, US National Science Foundation, BoxGroup and DCVC. By type, the record holds 11 venture capital firms. The early-stage round in Feb 2020 drew 38 investors.
About Culture Biosciences
Developer of automated bioreactors and software designed to help companies optimize their manufacturing processes. The company designs, monitors, and analyzes bioreactors for sensitive cell cultures and high cell density fermentation, enabling biotech companies to optimize manufacturing processes and simulate performance at scale.
- Sector
- Healthcare
- HQ
- South San Francisco, CA, United States
- Founded
- 2016
- Employees
- 80
- Website
- culturebiosciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.